Central to the regulation of cellular proliferation and differentiation are the mechanisms by which external stimuli influence intracellular processes. Signal transduction at sites of membrane-substrate contact are mediated by transmembrane receptors, and several associated intracellular cytoskeletal proteins. The proto-oncogene encoded protein, Vav, is a multifunctional protein that has been shown to mediate signaling in several Rho/Rac pathways involved in cytoskeletal control. To gain a better understanding of the molecular mechanisms involved in such signaling, we have undertaken a genetic and molecular analysis of Vav in the nematode Caenorhabditis elegans. In mammals, Vav, and its family member, Vav-2, exhibit GEF activity for the Rac GTPase. Rac has been implicated in the control of cytoskeletal reorganization through the stimulation of actin polymerization at focal contacts and newly forming lamellipodia. In addition to GEF function, Vav contains a number of other structural motifs. Vav is potentially localized to the membrane through its pleckstrin-homology (PH) domain, where it could participate in a variety of protein-protein interactions. For example, Vav has been shown to bind to the focal adhesion scaffolding protein, zyxin, through its carboxy-terminal SH3 domain. Lastly, Vav contains an amino-terminal calponin-homology (CH) domain that could function in actin binding. Deletion of this domain results in oncogenesis, producing dense, non-refractile foci in NIH3T3 cells, and tumors in nude mice. Clearly, such a multifunctional protein will play key roles in the control of diverse intracellular signaling events. The study of Vav in C. elegans will contribute a novel approach to the understanding of such signaling mechanisms. Recently, the C. elegans genome sequencing project identified a vav homolog in the nematode that is located on linkage group III. We have screened a cDNA library provided by Robert Barstead to isolate a full-length cDNA encoding
vav-1 in C. elegans. This vav-like protein (Vav-1) is highly homologous to mammalian Vav, containing an overall 55% identity with the murine protein. The predicted protein contains many of the structural motifs found in mammalian Vav, such as an amino terminal calponin homology (CH) domain, central GEF and PH domains, and a carboxy-terminal SH2 domain. To identify the cellular localization of this signaling protein, we constructed several fusions of
vav-1 to a reporter gene encoding Green Fluorescent Protein (GFP). In transgenic strains that express these fusion proteins, we identified expression primarily in neurons and muscle. In order to determine the function of Vav-1, in vivo, we have taken two different approaches to disrupt Vav function: RNA-mediated interference, and Tc1-transposon based mutagenesis. Using a PCR-based strategy, we identified a strain containing a Tc1 transposon in exon 4 of the
vav-1 gene. This strain is viable and exhibits no obvious phenotype on preliminary analysis. Rigorous phenotypic analysis of this strain, and strains derived from imprecise excision of the transposon, are currently in progress.